Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreFor years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
At the end of 2021, China implemented electronic Common Technical Document (eCTD) submissions to accelerate the review and approval of new pharmaceuticals. eCTDs ultimately benefit pharmaceutical and biotech companies by expediting review times, which means faster approvals and a faster time to market. For the regulatory authorities, eCTDs enable more efficient review processes. Although this is a huge step forward for standardization in the Asia Pacific, there are several important things you need to know before you submit your dossier electronically.
Here are eight things you need to know.
Related Insights
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Biosimilar Development: Are therapeutic clinical trials needed?
Nov 16, 2021
Webinar
EU-CTR: Preparing for trial transition
Nov 30, 2023
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Podcast
Pharma Talk Radio: Building a Successful Relationship with your Development Partner
Oct 5, 2021